February 10, 2017 06:14 AM EST
R&D

Dai­ichi Sankyo shut­ters an­oth­er R&D cen­ter in an on­go­ing glob­al over­haul

John Carroll

Editor & Founder

Dai­ichi Phar­ma is clos­ing an­oth­er R&D di­vi­sion. A month af­ter the Japan­ese phar­ma put out the word that it was clos­ing a re­search fa­cil­i­ty in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

A service from the Financial Times